Cyanidin-3-O-β-glucoside (C3G) inhibits the caspase 3, caspase 9, Bax and JNK pathways by reducing hyperglycemia-induced oxidative stress and related mitochondrial disorders to improve MAFLD [42]. This evidence concerns the gene BAX and Hyperglycemia.